Mkt and Stem Cells Down Again Wednesday 9.2

Wednesday 9.2.09:
DOW -30(.3%) @9,281..NAS -1.8(.09%) @1,967..SP500 -3.3(.33%) @994.75

BIO-Stem Index: -2.47(-1.8%) @137.18 (+37.18% ytd)
BIO-ETF Index: -.22(-.2%) @110.63 (+10.64% ytd
[Stem cell index beating biotech by 24%]

The market was flat most of the day Wednesday, then fell .3% at the close. Stem cells fell 1.8% however (our index), while the biotech ETFs only fell .2%. Stem cell stocks overall: only 14 up, 15 down, 2 unchanged. MEDX is now gone, acquired by Bristol-Myers Squibb. SVA gave back 18.5% today, after doubling in a week.

Stem Cell Stocks (14 up, 15 down, 2 n.c.)
Big Winners: ATHX +2.1%, CUR +2.8%, GERN +2.2%, LMNX +2%
Losers: ARIA -3.4%, AVII -14.4%, OSIR -2.8%, SQNM -2.7%

Swine Flu Stocks
AVII -14.4%, BCRX -4.5%, DVAX +2.4%, GILD +.4%, INHX -8.3, INO -1.4%, NVAX -10.7%, SIGA +5%, SVA -18.5%
Other Flu: APT -6.9%, HEB -5.2%, VICL -7.7%

Other Biotech
Big Winners: ACAD +7.5%, CRXL +2.4%, DSCO +2.1%, ENZN +2.1%, EXEL +2.5%, IMMU +2.9%, KVA +31.5%, LMNX +2%, NBIX +9.4%, NEOG +7.95%, ONCY +2.3%, PGNX +2.1%, PLX +3.4%, SGMO +4.6%, SIGA +5%
Losers: ANDS -10.2%, ARIA -3.4%, CPRX -13.1%, HGSI -5.9%, JAV -5.4%, JAZZ -4.3%, TRBN -9.7%, XOMA -4.8%

Big Volume: AFFX, AVII, OSIR, BCRX, NVAX, SIGA, SVA, APT, CRXL, PURE, ACAD, ALKS, ENZN, EXEL, IMMU, MED, NBIX, NEOG, PLX, SGEN, SIGA

New Intraday Highs: NEOG (that's all..)

Disclosure: Long SPPI (drug decision due soon, another in Oct)